#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Encephalitis autoimmune Rosai-Dorfman syndrome Adrenocortical carcinoma Autologous haematopoietic stem cell transplant Acute respiratory distress syndrome Hereditary haemorrhagic telangiectasia Carcinoid tumour Stargardt's disease Bladder cancer Primary mediastinal large B-cell lymphoma Congenital hypotransferrinaemia Congenital leptin deficiency Acute hepatic failure Congenital pseudarthrosis Langerhans' cell histiocytosis More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Trials in Disease Ocular melanoma – Treatment Nephroblastoma – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Rhabdoid tumour – Basic Information Wolfram syndrome Hereditary neuropathic amyloidosis – Trials in Disease Adrenocortical carcinoma – Treatment Alport’s syndrome – Trials in Disease Alveolar rhabdomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexamethasone Base Pd01B Gremubamab Azd8205 68Ga-Dpi-4452 Belatacept Pentoxifylline POTASSIUM HYDROXIDE Alendronate Sodium Monohydrate Irbesartan Molidustat Sodium Mk-1167 Hydrocortisone Hemisuccinate Orlistat Mps-102 Ltx-315 Desflurane Apadamtase Alfa Magnesium Oxybate Abc-16F-116 More therapies…

    Learn about Your Condition

    Breast cancer stage III Colorectal adenoma Breast cancer Femur fracture Arteriovenous malformation Embolic stroke Cleft lip and palate Angiosarcoma non-metastatic Juvenile spondyloarthritis Incisional hernia Thalassaemia alpha Paresis Malignant oligodendroglioma Venous thrombosis Haemorrhoids More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study of MK-2214 to slow disease progression in people with early Alzheimer’s disease

    Recruiting

    2 1
    Investigated Drugs:
    • Florquinitau (18F)
    Belgium The Netherlands Spain

  • Study of Cerebrolysin to improve arm function in patients recovering from ischemic stroke

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Cerebrolysin Concentrate
    • Sodium Chloride
    Romania

  • Study of intestinal gel containing levodopa, carbidopa and entacapone to treat motor and behavioral symptoms in patients with Parkinson’s disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Levodopa
    Germany

  • Study of ALKS 2680 to treat excessive daytime sleepiness in people with idiopathic hypersomnia

    Recruiting

    2 1
    Investigated Diseases:
    • Hypersomnia
    Investigated Drugs:
    • Alks 2680
    Belgium Czechia France Italy The Netherlands Spain

  • Study of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis

    Recruiting

    2 1
    Czechia Germany Poland

  • Study of Remternetug for Prevention of Disease Progression in People at Risk for or With Early Onset Inherited Alzheimer’s Disease

    Recruiting

    4 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • LY3372993
    • N-Methyl-2-(4′-Methylaminophenyl)-6-Hydroxybenzothiazole
    France Germany Italy The Netherlands Spain
Previous Page
1 … 13 14 15 16 17 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!